Invesco
NUVL

Invesco’s Nuvalent NUVL Stock Holding History

Invesco’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.8M Sell
408,285
-31,015
-7% -$3.16M ﹤0.01% 1141
2025
Q4 		$44.2M Buy
439,300
+405,543
+1,201% +$40M ﹤0.01% 1129
2025
Q3 		$2.92M Sell
33,757
-4,281
-11% -$338K ﹤0.01% 2469
2025
Q2 		$2.9M Sell
38,038
-27,636
-42% -$2.02M ﹤0.01% 2428
2025
Q1 		$4.66M Buy
65,674
+2,149
+3% +$168K ﹤0.01% 2195
2024
Q4 		$4.97M Sell
63,525
-106,921
-63% -$9.98M ﹤0.01% 2252
2024
Q3 		$17.4M Buy
170,446
+155,226
+1,020% +$12.9M ﹤0.01% 1529
2024
Q2 		$1.15M Sell
15,220
-179,922
-92% -$12.8M ﹤0.01% 2859
2024
Q1 		$14.7M Buy
195,142
+24,543
+14% +$1.95M ﹤0.01% 1607
2023
Q4 		$12.6M Sell
170,599
-38,088
-18% -$2.36M ﹤0.01% 1675
2023
Q3 		$9.59M Buy
208,687
+70,673
+51% +$3.14M ﹤0.01% 1787
2023
Q2 		$5.82M Buy
+138,014
New +$5.22M ﹤0.01% 2156
2023
Q1 		– Sell
-74,439
Closed -$2.22M – 3958
2022
Q4 		$2.22M Sell
74,439
-9,684
-12% -$270K ﹤0.01% 2604
2022
Q3 		$1.64M Buy
+84,123
New +$1.41M ﹤0.01% 2730

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco's NUVL Position: Q1 2026 in Review

Invesco reduced its Nuvalent (NUVL) stake by 7.1% in Q1 2026, selling an estimated $3.16M and leaving 408,285 shares worth $41.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

Invesco first reported a position in NUVL in Q3 2022 and has held it in 14 quarters since. The position peaked at $44.2M in Q4 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Invesco held 408,285 shares of Nuvalent worth $41.8M as of Q1 2026.
  • Invesco sold 31,015 Nuvalent shares in Q1 2026, an estimated $3.16M.
  • Nuvalent made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #1141 holding.
  • Invesco first reported a position in Nuvalent in Q3 2022 and has held it in 14 quarters since.
  • Invesco's Nuvalent position peaked at $44.2M in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.